Advances And Progress In Drug Design 2011

Advances and Progress in Drug Design 2011 is a major pharma conference in Europe that will intend to address the latest developments in drug design, together with concrete examples of these processes in practice. The conference will enable the delegates to meet with senior representatives, from all the leading pharmaceutical companies and share thoughts and experiences. It will offer an unrivalled opportunity to hear some of the most important and influential experts on the latest developments in computational drug design and to explore structure based techniques for compound design. The 9th Annual Advances and Progress in Drug Design Conference 2011 will focus on numerous major topics, such as: Challenges in drug design, NNRTI design: structure based approaches, Hybrid docking, Transforming GPCR drug discovery, GPCR models as tools for structure-based design, Fragment optimisation, Optimising fragments using structure-based drug design, Fragment-based discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL, etc.

The targeted visitors at the 10th Annual Advances and Progress in Drug Design Conference 2011 are Chief Executives, Vice Presidents, Heads, Directors, Scientists and Project Leaders of: